Disc Medicine Inc (IRON)
31.92
+0.06
(+0.19%)
USD |
NASDAQ |
May 16, 16:00
31.96
+0.04
(+0.11%)
After-Hours: 20:00
Disc Medicine Enterprise Value: 446.50M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 446.50M |
| May 15, 2024 | 445.02M |
| May 14, 2024 | 444.52M |
| May 13, 2024 | 424.00M |
| May 10, 2024 | 407.94M |
| May 09, 2024 | 418.07M |
| May 08, 2024 | 382.72M |
| May 07, 2024 | 400.02M |
| May 06, 2024 | 403.24M |
| May 03, 2024 | 393.84M |
| May 02, 2024 | 374.31M |
| May 01, 2024 | 362.69M |
| April 30, 2024 | 345.63M |
| April 29, 2024 | 356.76M |
| April 26, 2024 | 338.46M |
| April 25, 2024 | 313.00M |
| April 24, 2024 | 332.28M |
| April 23, 2024 | 324.87M |
| April 22, 2024 | 324.37M |
| April 19, 2024 | 366.64M |
| April 18, 2024 | 399.52M |
| April 17, 2024 | 405.95M |
| April 16, 2024 | 397.30M |
| April 15, 2024 | 411.89M |
| April 12, 2024 | 443.46M |
| Date | Value |
|---|---|
| April 11, 2024 | 448.64M |
| April 10, 2024 | 435.80M |
| April 09, 2024 | 449.63M |
| April 08, 2024 | 442.22M |
| April 05, 2024 | 400.73M |
| April 04, 2024 | 385.91M |
| April 03, 2024 | 410.61M |
| April 02, 2024 | 448.52M |
| April 01, 2024 | 502.23M |
| March 28, 2024 | 1.176B |
| March 27, 2024 | 1.133B |
| March 26, 2024 | 1.128B |
| March 25, 2024 | 1.108B |
| March 22, 2024 | 1.136B |
| March 21, 2024 | 1.155B |
| March 20, 2024 | 1.278B |
| March 19, 2024 | 1.309B |
| March 18, 2024 | 1.270B |
| March 15, 2024 | 1.164B |
| March 14, 2024 | 1.195B |
| March 13, 2024 | 1.255B |
| March 12, 2024 | 1.210B |
| March 11, 2024 | 1.230B |
| March 08, 2024 | 1.251B |
| March 07, 2024 | 1.186B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-62.17M
Minimum
May 26 2022
1.499B
Maximum
Mar 01 2024
314.60M
Average
140.01M
Median
Enterprise Value Benchmarks
| Neogen Corp | 3.624B |
| SIGA Technologies Inc | 418.00M |
| AbbVie Inc | 346.19B |
| Bristol-Myers Squibb Co | 135.48B |
| Amylyx Pharmaceuticals Inc | -248.84M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -26.95M |
| Total Expenses (Quarterly) | 31.46M |
| EPS Diluted (Quarterly) | -1.09 |
| Earnings Yield | -10.59% |